We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
CISATRACURIUM MEDICIANZ (Medsurge Pharma Pty Ltd)
Product name
CISATRACURIUM MEDICIANZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
147 (255 working days)
Active ingredients
cisatracurium besilate
Registration type
New generic medicine
Indication
Cisatracurium injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. It is used as adjunct to general anaesthesia, or sedation in the Intensive Care Unit.
Registration process
First generic
First approval of a medicine that contains the same active ingredient as and is bioequivalent to an existing medicine